Research Article | Open Access
In Vitro and In Vivo Anti-Salmonella Evaluation of Pectin Extracts and Hydrolysates from “Cas Mango” (Spondias dulcis)
Background. The threat to human health posed by multidrug-resistant strains of Salmonella typhi (S. typhi) and Salmonella paratyphi (S. paratyphi) is of growing concern. Generally, there has been increasing resistance and even multidrug resistance to almost all classes of antibiotics. This has rendered treatment with antibiotics difficult and costly. The present study investigated the bioactivity of pectin and pectin hydrolysates derived from a local fruit, Spondias dulcis, against four strains of Salmonellae. Methods. Pectin was extracted from alcohol extractives-free peel by acidic hydrolysis at a temperature of 80°C for one hour at pH 2 and 4. The pectin was precipitated with 95% alcohol at an extract to alcohol ratio of 1:10 v/v. Antimicrobial activity was determined using agar well diffusion technique. The minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) values were determined using the broth dilution technique. An in vivo study was then carried out with the bioactive extracts against the most resistant bacteria strain, to fully establish the therapeutic effect of these extracts. Balb/C mice were used, and ciprofloxacin was the positive control antibiotic. The extracts were administered to mice at two doses, 5mg/Kg and 10mg/Kg. The efficacy of extracts in the treatment of typhoid was evaluated based on survival rate, change in body weight, and change in bacteria load. Results. Only one of the extracts (crude pectin pH 2.5) was active against all the Salmonellae by well diffusion, and the growth inhibition varied from 12mm to 15mm at100 μg/ml. Three of the extracts (crude pectin pH 2.5, pH 4, 12h hydrolysate, and pH 4, 1h hydrolysate) had MIC and MBC against all four Salmonellae strains with MIC ranging from 5.68 to 44.45 μg/ml and MBC from 11.36 to 44.45 μg/mL. Three treatments, namely, the pH4-12 hr, hydrolysate at 10mg/Kg and 5mg/Kg, and the pH4-1hr, hydrolysate at 10mg/Kg, had therapeutic effects against Salmonella infection in mice. Conclusion. The present study highlights the potential of pectin oligosaccharides as new source of anti-Salmonella drugs. Further investigations including exploration of mechanism of action of the most active pectin extracts/hydrolysates are envisaged.
Typhoid fever is a systemic prolonged febrile illness caused by certain Salmonella serotypes. Serovars Typhi and Paratyphi of this serotype, Salmonella enteric subspecies enterica, are the etiologic agents that cause typhoid and paratyphoid fevers, respectively. Typhoid fever is encountered worldwide but primarily prevalent in developing countries. The risk factors for typhoid are similar to those of cholera and other epidemic prone diarrheal diseases and are mainly related to access to safe water and the functionality of sanitation systems as well as food safety. It commonly presents with a sudden onset of fever, headache, abdominal pain, and diarrhea and can quickly progress to a variety of potentially fatal complications, including gastrointestinal haemorrhage and intestinal perforation. Even though the infection is often curable with antibiotics, the growing prevalence of resistance makes vaccination of vulnerable groups an increasingly urgent priority and the search for new antimicrobial agents against Salmonella species.
Pectin is a complex mixture of polysaccharides that makes up about one-third of the cell wall dry substances of higher plants . Although pectin was discovered over 220 years ago, its structure and composition are not yet completely elucidated . This is probably because pectin structure can change during extraction from plants, storage, and processing. Presently, pectin is thought to be mainly composed of 1-4 linked α-D-galacturonic acid . Plant fruits, both pulp and the rind, generally contain the highest amounts of pectin compared to other parts of plants. Citrus peel and apple pomace are currently the main source of commercial pectin. Pomace has about 15% of wet pectin while citrus peel such as orange and grape fruit has 30% of wet pectin . The use of pectin and pectin oligosaccharides in the prevention and treatment of human ailments is a recent practice. Pectin and combinations of pectin with other colloids have been used extensively to treat diarrheal diseases, especially in infants and children . Pectins are found to have antimicrobial potential against the methicillin resistant Staphylococcus aureus and Aspergillus niger . Pectin also showed antibacterial activity against Helicobacter pylori .
Pectin oligosaccharides are produced from pectin by enzymatic treatment or acid hydrolysis, which for the most part is composed of galacturonic acid, with few rhamnose units in between, from where the arabinan and galactan units branch out . The structure is based on the source and the processing treatment . Functional oligosaccharides have been found effective in gastrointestinal normal flora proliferation and pathogen suppression, dental caries prevention, enhancement of immunity, facilitation of mineral absorption, source of antioxidant, antibiotic alternative, regulators of blood glucose in diabetics, and serum lipids in hyperlipidemics . Xylooligosaccharides in pharmaceutical preparations exhibit antiallergy, antimicrobial, anti-infection, and anti-inflammatory properties, selective cytotoxicity, and immunomodulatory action .
Spondias dulcis (synonym: Spondias cytherea) commonly known as ambarella and “cas mango” in Cameroon is a tropical tree with edible fruits containing a fibrous pit. This fast-growing plant is usually between 10 and 12 meters high. S. dulcis has deciduous, pinnate leaves, 20–60 cm in length, composed of 9 to 25 glossy, elliptic, or obovate-oblong leaflets 9–10 cm long, which are finely toothed toward the apex. S. dulcis has diverse traditional uses of its fruits, leaves, and bark in different parts of the world. Its leaves and shoots are used as a remedy for diarrhea . There has been an extensive review on the medicinal properties of S. dulcis. The roots, leaves, flowers, fruits, and especially bark are used to treat myriad medical problems such as wounds, fever dysentery, vaginal bleeding, genital ulcers, respiratory conditions, and intestinal and digestive ailments . S. dulcis peel is a major source of pectin, which is generally discarded as being of no nutritional use.
This study was therefore prompted, aiming at exploring pectin extract and oligosaccharides (pectin hydrolysates) obtained from the peel of a local Cameroonian fruit of Spondias dulcis as a potential source of anti-Salmonella therapy.
2. Materials and Methods
All reagents used were obtained from Sigma Aldrich, Germany.
2.1. Acquisition of Fruits
The cas mango fruits were obtained from a local market in Douala Cameroon. Fruits were carried in sterile bags and stored in the refrigerator at 4°C prior to its use. The fruits were then washed with tap water and then rewashed with 20% detergent in distilled water and rinsed twice in distilled water.
2.2. Extraction of Pectin
The procedure for pectin extraction was designed such that the yield of pectin in two different extraction conditions could be compared .
The fruit peels were weighed and blended with water in a ratio of 1:2 (w/v). The sludge was transferred into two 1500 ml beakers and the adjusted to 2.5 and 4 using 0.5M HCl and 0.5M NaOH. A volume of 500 mL portions of the sludge was refluxed at 70°C for 30 minutes and allowed to cool. The sludge was filtered using a moistened cheese cloth, ensuring the removal of maximum liquid. The volume of filtrate obtained was noted. Boiling 95% ethanol (about 60-80°C) was then added to the filtrate in a ratio of 1:1(v/v) and left to stand for 15 minutes. Pectin was obtained as a gelatinous precipitate. This precipitate was filtered with Watman filter paper number 1. The same procedure was followed for all other batches of sludge. Pectin precipitates were stored at 4°C.
2.3. Purification of Pectin
In order to purify the pectin, it was redissolved with distilled water in a ratio of 1:2 (w/v) at 100°C in a water bath. The dissolved pectin was then reprecipitated with 95% boiling ethanol in a ratio of 1:1(w/v) and filtered with Whatman filter paper number 1. This process was repeated trice and the purified pectin stored at 4°C in air tight containers in order to preserve the quality.
Fifty grams (50 g) of crude pectin and purified pectin was oven dried over at 60°C in order to determine the actual amount of dry pectin which can be derived from the pectin gel.
2.4. Identification of Pectin
The extracted pectin was qualitatively determined by the following tests.
2.5. Test with 95% Ethanol
On adding an equal volume of ethanol (95%) to 1% w/v solution of pectin sample, a gelatinous precipitate produced was taken as positive test .
2.6. Test with Potassium Hydroxide (KOH)
To 5ml of a 1% w/v solution of pectin sample, 1ml of a 2% w/v solution of KOH was added and set aside for 15 minutes. A transparent semigel will be produced. When the above gel is acidified with dilute HCl and shaken well, a gelatinous precipitate is formed. Upon boiling, this precipitate will became white and flocculent.
2.7. Pectin Hydrolysis
Mixtures of pectin hydrolysates were obtained by incubating “ambarella” pectin in Erlenmeyer flasks in a water (35°C) bath with shaking, with an appropriate amount of endopolygalacturonase (EPG) at 35°C for different reaction times. The reaction mixtures contained 1% pectin solution (w/v), 0.15 M NaCl in acetate buffer (0.05 M), and 0.15 mg ml-1 of endopolygalacturonase (w/v) and the pH adjusted to 6 using HCl and NaOH. In order to obtain different types of pectin hydrolysates, the following conditions were applied: (i) to obtain from pentamers to octamers, the reaction mixture was incubated in the water bath at (35°C) for 1 hour at pH 6.0; (ii) for dimer to pentamer the reaction mixture was incubated in the water bath at (35°C) for 12 hours at pH 6.0. In both cases, the enzymatic reactions were terminated by heating the solutions for 5 minutes at 100°C. Commercial pectin was used as a control. The KOH test for pectin was used to confirm the complete degeneration of pectin by the enzyme.
2.8. Antimicrobial Activities
2.8.1. Microorganisms and Culture Media
Four bacterial strains were used for this study, 3 laboratory strains, and one clinical strain. The laboratory strains (Salmonella enterica typhimurium ATTC 2680, Salmonella enterica typhimurium ATTC 2488, and Salmonella choleraesuis) from the American Type Culture Collection (ATCC) were kindly donated by BEI-Resources, Manassas, USA. Nutrient agar was used for activation and routine maintenance of the strains.
The clinical strain of Salmonella was obtained from Buea Regional Hospital Laboratory, subcultured several times on Salmonella Shigella (SS) agar to obtain pure and single bacterial colonies. The colonies were subcultured on Nutrient agar and characterized using Kliger Iron Agar (KIA).
2.8.2. Determination of In Vitro Anti-Salmonella Activity of Pectin and Pectin Hydrolysates
The extracted pectin in solution and the pool of unfractionated hydrolysates were evaluated for in vitro antimicrobial activity at 100μg/ml
(a) Inhibition Zone Diameters. These tests were performed using the agar well diffusion method described by Tabouguia et al. , with some modifications. The inocula were prepared by dissolving 3 to 5 bacterial colonies from 24-hour culture of Nutrient agar in sterile saline (0.9% NaCl). The turbidity was then adjusted to match 0.5 McFarl and standard turbidity (108 CFU/ml). Muller Hinton Agar (20ml) was poured into each of the 90mm Petri dishes. The bacterial suspension (100 μl) was uniformly spread on an MH medium using a Pasteur pipette and allowed to dry. Using a sterile borer, 6mm diameter wells were bore on the agar. 60 μl, of each of the test solutions, and the negative control (60 μl of saline) and positive controls (ceftriaxone) were carefully added into designated wells on the surface of the agar containing the bacteria. The plates were kept for 30 minutes and then incubated at 37±1°C for 24h. The plates were examined for growth and the zones of inhibition measured using a ruler. The endpoint of inhibition is where growth starts.
2.8.3. Determination of MIC and MBC
The broth dilution method  was adopted for determination of MIC and MBC values against the pathogens, using 96 well plates. The pectin extracts and hydrolysates (100μg/ml) were serially diluted in different aliquots and the final volumes of the aliquots with Muller Hinton Broth. Equal amount of the specific pathogen (50μl) at McFarland’s turbidity was added in different aliquots and the well plates were kept for 24h at 37±1°C. The minimum concentration of the pectin extract that kills the bacterial was taken as MBC (Minimum Bacterial Concentration) while the minimum concentration that inhibits the growth of the organism was taken as MIC.
2.8.4. In Vivo Anti-Salmonella Activity of Preselected Extracts and Hydrolysates in Mouse Model
From the results of the in vitro antibacterial assay, one extract and two hydrolysates with significant activity were considered for in vivo testing against Salmonella enterica typhimurium ATTC 2860 Balb/c mouse model.
2.8.5. Ethical Considerations
The experiment was performed in accordance with ethical guidelines for the care and use of animals in research. The mice were kept in sterile mice cages at room temperature (27 ± 2°C), and a 12-hour cycle of light and dark. They were given access to animal feed pellet and water ad libitum. The proposal, describing the handling and treatment of animals, was reviewed and approved by the University of Buea Ethical Review Board for the Use of Animals in Research (UB-IACUC).
2.8.6. Infection and Treatment of Mice 
Forty-five Balb/c strain albino mice, all male, weight between 30 and 40g from the animal breeding unit of the Medical Research and Applied Biochemistry Laboratory, University of Buea, were used in the study. The mice body surface was wiped with 70% alcohol, and the animals were confirmed for the absence of any enteric infection using stool culture in both Mueller Hinton and Salmonella Shigella agar. The faeces collected were dissolved in saline distilled water (0.9% NaCl) at a proportion of 0.5g for 1mL of suspension. Aliquots (100 μL) of fecal suspensions in saline distilled water (0.9% NaCl) were then plated on Salmonella Shigella agar. The plates were incubated overnight at 37°C. Typical colonies were then identified and counted on the plates. For plates whose colonies were uncountable, the bacterial suspensions were serially diluted and cultured. The CFUs obtained from dilution were then multiplied by the dilution factor. Any animals found infected prior to the study were excluded from the study.
The animals to be infected were fasted for 3 hours (Groups A to G and I) and given by gavage 1mL of saline solution (0.9% NaCl) containing 3.0×108 CFU of the test microorganisms.
The animals were then maintained at room temperature [(23 ± 2)°C] with a 12 h light-dark cycle and standard animal feed and water were provided and feeding habits were monitored. To verify that infection, the bacterial load in the faeces of the animals was determined one day before infection and five and seven days following the infection, by stool culture as described above. Typical colonies were then counted. Table 1 shows how mice were distributed.
2.9. Statistical Analysis
Data obtained was expressed as mean ± SDEV. The different treatments were compared against controls and against each other using the Wilcoxon signed ranks test at 95% confidence intervals. Survival rate was expressed in percentages. Statistical Package for Social Sciences (SPSS) version 21.0 was used.
Yield of Pectin extracted and physicochemical characteristics of pectin extracts and their hydrolysates: the extraction yield was higher (6.98%) at pH 2.5, compared to 4.59 obtained at pH4. Table 2 summarizes the physicochemical characteristics of the different pectin extracts and their hydrolysates.
The same tests were used to qualitatively confirm hydrolysis and negative results were obtained.
3.1. Anti-Salmonella Activity of Pectin Extracts
3.1.1. In Vitro Activity
Table 3 summarizes the findings on dish diffusion test of the different pectin extracts and hydrolysates. The zones of inhibitions varied from 12 mm to 15.0 mm at 100 μg/ml. Salmonella clinical was most inhibited with an inhibition zone of 15 mm while Salmonella enterica typhimurium ATTC 2860 recorded the least zone of inhibition, 12mm.
Diameter of the wells: 6mm, all extracts which had a diameter zone of inhibition of 6mm were inactive on the bacteria.
3.2. Result of the Microplate Dilution Tests
The values of minimum inhibitory concentration (MIC) of the different extracts and hydrolysates are shown in Table 4.
ND = not determined.
3.3. In Vivo Anti-Salmonella Activity of Pectin and Hydrolysates in Mice
The three extracts which had significant MICs (Crude Extract pH 2, pH 4-1hr hydrolysate, and pH 4-12hr hydrolysate) were screened against the Salmonella specie with the least
MIC values were Salmonella enterica typhimurium 2860. Balb/C mice were infected orally with this bacterium and the extracts administered to them orally at two different doses. The efficacy of the extracts was evaluated considering bacteria load in faeces, mortality, and morbidity (body weight, physical activity, nature of the stools, signs of fever, etc.)
3.4. Effect of Pectin and Its Hydrolysates on Survival Rate of Salmonella-Infected Mice
Survival rate of animals during treatment ranged from 25% to 100% (see Figure 1). Treatment of infected mice with all extracts led to an increase in life span compared to the vehicle group, except crude pectin pH 2.5 (10mg/Kg) where 75% of the animals died.
3.5. Effect of the Pectin and Hydrolysates on Morbidity of Salmonella-Infected Mice
Body weight: Figure 2 illustrate variation in body weigh with reference to the treatment. The body weight did not show any significant (P > 0.05) differences between the treated groups and the positive control (infected and treated with ciprofloxacin) except for crude pectin 5mg/Kg which showed significance (P < 0.05) from day 6 till day 10, and pectin hydrolysate 12 hours and 10mg/Kg which showed significance from day 4 till day 10.
(a) Crude pectin
(b) pH 4-1hr
(c) pH 4-12hr
The normal group (noninfected animals, with no treatment) witnessed a constant increase, contrary to the gradual decrease observed in infected mice receiving without treatment (receiving only distilled water). Mice who received crude pectin at 5mg/Kg lost weight up till day 2, and then a slight but steady increase till day 10. There was a drastic drop in weight for mice that were treated with crude pectin 10mg/kg. The weight loss was greater than that in the negative control. Mice treated with pH 4-1hr, 5mg/Kg experienced a decrease in body weight till day 2 and increase in day 4, a decrease in day 8, and then an increase in day 10. pH 4-1hr, 10mg/Kg treated mice had a decrease in body weight till day 4 and then a constant increase till day 10. Mice who received pH4-12hrs, 5mg/Kg experienced a decrease in body weight while those who were treated with pH 4-12hr, 10mg/Kg had a steady rise in weight and started recovering faster than animals that were treated with ciprofloxacin.
3.6. Effect of Pectin Extract and Hydrolysates on S. enterica typhimurium 2860 Bacterial Load
The bacteria load in mice was evaluated by colony counts per ml of Salmonella in 0.5g of faeces. After induction, CFUs ranged from 0 to 2720 (Figure 3). Treatment of infected mice with the extracts and ciprofloxacin significantly decreased (p < 0.05) colony counts of Salmonella in some groups, compared to the pretreatment values.
Figure 3 shows the change in CFU at the beginning and the end of the experiment.
During treatment three of the treated groups recorded steady decrease in bacteria load and three experienced an increase. Mice treated with crude pectin 5mg/Kg, crude pectin 10mg/Kg, and pH-1hr, 5mg/Kg experienced an increase in bacteria load while mice treated with pH-1hr, 10mg/ Kg, PH-12hr, 5mg/Kg, and PH-12hr, 10mg/Kg had a relative decrease in bacteria load.
The emergence of multidrug resistance in Salmonella species has rendered most existing therapies ineffective or suboptimal for the treatment of typhoid fever. In addition to resistance induction, antibiotics are sometimes associated with opposing side effects such as hypersensitivity, immune-suppression, and allergic reactions. It is therefore important to identify new sources of antimicrobial agents for the treatment of infectious diseases such as typhoid. Pectin and pectin oligosaccharides have been identified as sources of antibacterial and antiadhesive agents especially against enteric bacteria. Pectin extracted from “ambarella” or “cas mango” and its hydrolysates were tested for their anti-Salmonella typhi activity in vitro, and the active extracts were later screened for their efficacy in infected mice. Four test organisms were used for the study, three laboratory strains and one clinical isolate.
The antimicrobial susceptibility test showed that only one out of all eleven extracts was active on all the Salmonella species with zones of inhibition ranging from 12 mm to 15 mm at a concentration 100μg/ml. The zones of inhibition of microbial growth are a function of antimicrobial activity of the extracts. However it depends on the solubility and diffusion capacity of the tested products. Crude pectin (2.5) was the only active extract in vitro with a diameter of 15mm on Salmonella clinical and least 12mm on S. enterica typhimurium 2860.
From dilution method, the MIC values ranged from 5.68μg/ml to 44.45μg/ml. Crude pectin (2.5) had the least MIC values for all four Salmonella strains, indicating that it was the most active extract. Also, this pectin had MBC values for all four strains confirming that the extract did not only inhibit bacterial growth but could kill bacteria at certain concentrations. These results correlate with previous findings by Mathur et al.  and Niharika and Abhishek . Both researchers established the antimicrobial activity of pectin extracted from apple pomace and citrus peel on E. coli and methicillin resistant Staph aureus. Pectin (pH4.0) hydrolyzed with EPG at 1 hour and 12 hours had similar MICs for all strains except Salmonella choleraesuis where the 1-hour hydrolysate had an MIC of 44.45μg/ml and the 12-hour hydrolysate an MIC of 22.7μg/ml. This suggests that both hydrolysates have almost the same potency against the Salmonellae. The 1-hour hydrolysate was bactericidal at 44.45 μg/mL for all species except Salmonella clinical while the 12-hour hydrolysate was bactericidal at 22.7 μg/mL for all species except Salmonella clinical. Thus both hydrolysates only inhibited the growth of Salmonella clinical but did not kill the bacteria at any concentration. Generally, it was established that the pectin oligosaccharides found in both hydrolysates had an antibacterial activity against Salmonella species in vitro by microdilution. This correlates with results obtained by Lee and Lee  who established that Eucosterol Oligosaccharide Isolated from Bulb of Squil Plant had antibacterial activity against E. coli, Salmonella typhimurium, and Staphylococcus aureus. Generally, it was observed that crude pectin (pH2.5) lost its antibacterial potency upon purification and hydrolysis while crude pectin (pH4.0) instead gained antimicrobial potency upon purification and hydrolysis. This can be explained by the fact that extraction conditions such as and other physic-chemical processes affect the chemical characteristics of pectin from various plant tissues [2, 17–20]. Purification and hydrolysis may have destroyed or introduced some side groups on pectin and its hydrolysates which either induces potency or inhibits potency.
Based on information provided by the in vitro antibacterial assay and particularly the microdilution test results, an in vivo study was undertaken in a bid to verifying the therapeutic efficacy of the active extracts. The efficacy was evaluated considering survival rate, body weight, and bacterial load (CFUs).
Treatment of infected mice with all extracts led to an increase in life span, except crude pectin 2 (10mg/Kg) where 75% of the animals died during treatment. The death of mice who received crude pectin 10mg/Kg suggests that the concentration was toxic to the mice, considering the fact that 100% of mice who received a lower dose of 5mg/Kg survived. In general, the mean body weight of all typhoid-infected groups reduced very significantly (p = 0.00) after induction of typhoid (weight range initial 30.1-40.0 (34±2.64) g, weight range after infection was 27-39g; 32.87±3.01). The decrease in body weight by all infected animals could be attributed to the various pathophysiological effects that are produced during Salmonella infection in mice like diarrhea, fever, and loss of appetite . The body weights did not show any significant (P > 0.05) differences between the treated groups and the positive control (infected and treated with ciprofloxacin) except for crude pectin 5mg/Kg which showed significance (P < 0.05) from day 6 till day 10, and pectin hydrolyzed 12 hours which showed significance from day 4 till day 10. Except for crude pectin 10 mg/kg, all the test groups and the positive control experienced a decrease in body weight till day 2, followed by a steady recovery up to day 10. Results of the on bacteria load showed that after administration of the aqueous extracts, three of them inhibited the growth of S. typhimurium and thus reduced the numbers of viable bacterial CFU recovered from faeces. This reduction was dose-dependent in animals infected and treated. The marked reduction bacteria load confirmed the antimicrobial potency of the hydrolysates and therefore suggests its efficacy in the treatment of typhoid fever. These results showing the anti-Salmonella potential of pectin and hydrolysates, corroborate those obtained by Searle et al.  who established that a mixture containing galacto-oligosaccharides, produced by the enzymatic activity of Bifidobacterium bifidum, reduces Salmonella enterica serovar typhimurium infection in mice.
Mice treated with crude pectin 5mg/Kg, crude pectin 10mg/Kg, and pH-1hr 5mg experienced an increase in bacteria load, indicating the inefficiency of the crude pectin. Considering the above three parameters, survival rate, body weight, and bacterial clearance, the results of this study indicate pectin hydrolysate 12 hours, 10mg/Kg had the highest efficacy in the treatment of typhoid fever, followed by pectin hydrolysate 12 hours, 5mg/Kg, and then pectin hydrolysate 1 hour, 10mg/Kg.
Previous studies that involved evaluating functionalities of different oligosaccharides showed the tremendous potential of oligosaccharides in various aspects related to health and disease. Functional oligosaccharides have been found effective in gastrointestinal normal flora proliferation and pathogen suppression, dental caries prevention, enhancement of immunity, facilitation of mineral absorption, source of antioxidant, antibiotic alternative, regulators of blood glucose in diabetics, and serum lipids in hyperlipidemics . Xylooligosaccharides in pharmaceutical preparations exhibit antiallergy, antimicrobial, anti-infection, and anti-inflammatory properties, selective cytotoxicity, and immunomodulatory action . Haw pectin oligosaccharides (HPOS) showed dose and pH dependent antibacterial activity against E. coli.
Oligosaccharides have shown to also have the ability to protect against pathogen adhesion and invasion by receptor mimicry. Galacto oligosaccharide (GOS) reduced adherence of Enteropathogenic E. coli (EPEC) to Human HeLa contaminant carcinoma HEp-2 and the heterogeneous human epithelial colorectal adenocarcinoma Caco-2 cells in vitro; the antiadhesive activity of GOS was reported to be more effective than of both FOS and inulin . Similarly, GOS was found to reduce the invasion of S. Typhimurium SL1344 and LT2 to HT29 cells lines . Furthermore, pectin and pectic oligosaccharides reduced the activity of E. coli O157:H7 produced shiga toxin, likely by inhibiting binding of the toxin . From the present study, two pectin hydrolysates were identified from “cas mango” (Spondias dulcis), namely, the 4 1 hour and 12 hours hydrolysates, with significant activity and bactericidal effect on all four Salmonella species tested in vitro, and confirmed therapeutic effects on Salmonella typhimurium Balb/C mouse model of typhoid.
These findings are therefore a clear indication that pectin oligosaccharides might be a valuable and yet explored source of new anti-Salmonella therapies. Further investigations are required to fully characterize these oligosaccharides and gather more inside on their mechanism of action, as well as their safety.
|CFU:||Colony forming unit|
|HPOS:||Haw pectin oligosaccharides|
|MBC:||Minimum bactericidal concentration|
|MIC:||Minimum inhibitory concentration|
|UB-IACUC:||University of Buea Ethical Review Board for the Use of Animals in Research.|
The datasets used and/or analyzed during the current study are available from the corresponding author upon reasonable request.
The experiment was performed in accordance with ethical guidelines for the care and use of animals in research. The proposal, describing the handling and treatment of animals, was reviewed and approved by the University of Buea Ethical Review Board for the Use of Animals in Research (UB-IACUC).
Conflicts of Interest
The authors declare that they have no conflicts of interest.
Denis Zofou and Josepha Foba-Tendo conceived the work, oversaw the implementation process, provided research material, analyzed data, and drafted and edited the manuscript; Golda Lum Shu carried out bench work and drafted the manuscript; Merveille Octavie Tabouguia assisted in bench work and edited the manuscript; Jules-Clement N. Assob oversaw the implementation process and edited the manuscript.
The laboratory strains (Salmonella enterica typhimurium ATTC 2680, Salmonella enterica typhimurium ATTC 2488, and Salmonella choleraesuis) used in this study were kindly donated by BEI-Resources, Manassas, USA. The authors equally acknowledge the material and institutional support from the University of Buea (Cameroon). The present works benefited from a financial support from a Research Grant awarded to Dr. Denis Zofou by the International Foundation for Science (IFS Grant no. 5122-2F) and the World Academy of Sciences for the Advancement of Science in Developing Countries (TWAS) (TWAS, Trieste, Italy; Grant no. 14-150 RG/BIO/AF/AC_I–UNESCO FR: 324028598).
- B. Koubala, L. Mbome, G. Kansci et al., “Physicochemical properties of pectin from ambarella peels (spondiascytherea) obtained using different extraction conditions,” Food Chemistry, vol. 106, no. 3, pp. 1202–1207, 2008.
- K. Maazullah, B. Nizakat, and Z. Aurang, “Optimization of process conditions for pectin extraction from citrus peel,” Journal of Science, Technology and Development, vol. 34, no. 1, pp. 9–15, 2015.
- H. Garna, N. Mabon, K. Nott, B. Wathelet, and M. Paquot, “Kinetic of the hydrolysis of pectin galacturonic acid chains and quantification by ionic chromatography,” Food Chemistry, vol. 96, no. 3, pp. 477–484, 2006.
- M. H. Canteri-Schemin, H. C. R. Fertonani, N. Waszczynskyj, and G. Wosiacki, “Extraction of pectin from apple pomace,” Brazilian Archives of Biology and Technology, vol. 48, no. 2, pp. 259–266, 2005.
- G. R. Gibson, A. L. McCartney, and R. A. Rastall, “Prebiotics and resistance to gastrointestinal infections,” British Journal of Nutrition, vol. 93, pp. S31–S34, 2005.
- A. Mathur, V. Sharma, A. Bhardwaj et al., “Pectin content as an index for screening different varieties of Apple (Pyrusmalus L.) of Kashmir (J&K) on the basis of antimicrobial activity,” Journal of Chemical & Pharmaceutical Research, vol. 3, no. 2, pp. 886–891, 2011.
- Z. Daoud, M. Sura, and R. M. Abdel-Massih, “Pectin shows antibacterial activity against Helicobacter pylori,” Advances in Bioscience and Biotechnology, vol. 04, no. 02, pp. 273–277, 2013.
- A. G. J. Voragen, G.-J. Coenen, R. P. Verhoef, and H. A. Schols, “Pectin, a versatile polysaccharide present in plant cell walls,” Structural Chemistry, vol. 20, no. 2, pp. 263–275, 2009.
- S. I. Mussatto and I. M. Mancilha, “Non-digestible oligosaccharides: a review,” Carbohydrate Polymers, vol. 68, no. 3, pp. 587–597, 2007.
- A. Moure, P. Gullón, H. Domínguez, and J. C. Parajó, “Advances in the manufacture, purification and applications of xylo-oligosaccharides as food additives and nutraceuticals,” Process Biochemistry, vol. 41, no. 9, pp. 1913–1923, 2006.
- C. Boning, Florida's Best Fruiting Plants, Pineapple Press, Inc., Sarasota, Fla, USA, 2006.
- J. D. Mitchell and D. C. Daly, “A revision of Spondias L. (Anacardiaceae) in the neotropics,” PhytoKeys, vol. 55, no. 1, pp. 1–92, 2015.
- S. Niharika and M. Abhishek, “Evaluation of pharmacological effects of pectin extracted from apple pomace,” Bio Life Sciences, vol. 2, no. 4, pp. 1203–1217, 2014.
- O. M. Tabouguia, D. Zofou, J. A. Njouendou et al., “Antimicrobial activities of some medicinal plants against multi-resistant microorganisms causing urogenital tract infections in Cameroon,” Journal of Diseases and Medicinal Plants, vol. 10, pp. 2469–8210, 2017.
- M. E. Wickham, N. F. Brown, J. Provias, B. B. Brett, and B. K. Coombes, “Oral infection of mice with Salmonella enterica serovar Typhimurium causes meningitis and infection of the brain,” BMC Infectious Diseases, vol. 7, no. 1, 2007.
- J.-H. Lee, J. S. Shim, J. S. Lee, M.-K. Kim, M.-S. Chung, and K. H. Kim, “Pectin-like acidic polysaccharide from Panax gingseng with selective antiadhesive activity against pathogenic bacteria,” Carbohydrate Research, vol. 341, no. 9, pp. 1154–1163, 2006.
- S. Levigne, M.-C. Ralet, and J.-F. Thibault, “Characterisation of pectins extracted from fresh sugar beet under different conditions using an experimental design,” Carbohydrate Polymers, vol. 49, no. 2, pp. 145–153, 2002.
- L. Phatak, K. C. Chang, and G. Brown, “Isolation and characterization of pectin in sugar‐beet pulp,” Journal of Food Science, vol. 53, no. 3, pp. 830–833, 1988.
- B. M. Yapo, C. Robert, I. Etienne, B. Wathelet, and M. Paquot, “Effect of extraction conditions on the yield, purity and surface properties of sugar beet pulp pectin extracts,” Food Chemistry, vol. 100, no. 4, pp. 1356–1364, 2007.
- D. E. Brown, S. J. Libby, S. M. Moreland et al., “Salmonella enterica causes more severe inflammatory disease in C57/BL6,” 2013.
- L. E. J. Searle, A. Best, A. Nunez et al., “A mixture containing galacto-oligosaccharide, produced by the enzymatic activity of Bifidobacterium bifidum, reduces Salmonella enterica serovar Typhimurium infection in mice,” Journal of Medical Microbiology, vol. 58, no. 1, pp. 37–48, 2009.
- K. Shoaf, G. L. Mulvey, G. D. Armstrong, and R. W. Hutkins, “Prebiotic galacto-oligosaccharides reduce adherence of Entero-pathogenic Escherichia coli to tissue culture cells,” Infection and Immunity, vol. 74, no. 12, pp. 6920–6928, 2006.
Copyright © 2019 Denis Zofou et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.